INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "THERAPEUTIC COMBINATIONS OF AN AKT INHIBITOR, A BCL-2 INHIBITOR AND A GLUCOCORTICOID"

GENEVA, March 23 -- ASTRAZENECA AB (SE-151 85 Sodertalje) filed a patent application (PCT/EP2025/075667) for "THERAPEUTIC COMBINATIONS OF AN AKT INHIBITOR, A BCL-2 INHIBITOR, AND A GLUCOCORTICOID" on Sep 09, 2025. With publication no. WO/2026/057582, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BARRY, Simon (ASTRAZENECA UK LIMITED, 1 Francis Crick Avenue, Cambridge Biomedical CampusCambridge Cambridgeshire CB2 0AA), WILLIS, Brandon (ASTRAZENECA PHARMACEUTICALS LP, 1800 Concord Pike, P.O. Box 15437Wilmington, Delaware 1...